Label: READY FOUNDATION FAIR- titanium dioxide and zinc oxide powder
READY FOUNDATION FAIRLY LIGHT- titanium dioxide and zinc oxide powder
READY FOUNDATION GOLDEN FAIR- titanium dioxide and zinc oxide powder
READY FOUNDATION LIGHT- titanium dioxide and zinc oxide powder
READY FOUNDATION FAIRLY MEDIUM (titanium dioxide and .......K- titanium dioxide and zinc oxide powder
READY FOUNDATION MEDIUM DEEP- titanium dioxide and zinc oxide powder
READY FOUNDATION DEEPEST DEEP- titanium dioxide and zinc oxide powder
READY FOUNDATION GOLDEN DEEP- titanium dioxide and zinc oxide powder
READY FOUNDATION WARM DEEP- titanium dioxide and zinc oxide powder
-
Contains inactivated NDC Code(s)
NDC Code(s): 98132-163-08, 98132-164-08, 98132-165-08, 98132-166-08, view more98132-167-08, 98132-168-08, 98132-169-08, 98132-170-08, 98132-171-08, 98132-172-08, 98132-173-08, 98132-174-08, 98132-175-08, 98132-176-08, 98132-177-08, 98132-178-08, 98132-179-08, 98132-180-08, 98132-181-08, 98132-182-08 - Packager: Bare Escentuals Beauty Inc.
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
- Marketing Status: OTC monograph final
DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Drug Label Information
Updated October 1, 2014
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- SPL UNCLASSIFIED SECTION
- ACTIVE INGREDIENT
-
Uses
- helps prevent sunburn
- if used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun
- Warnings
-
Directions
For sunscreen use:
- apply liberally 15 minutes before sun exposure
- use a water resistant sunscreen if swimming or sweating
- reapply at least every 2 hours
- children under 6 months: ask a doctor
-
Sun protection measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF of 15 or higher and other sun protection measures including:
- limit time in the sun, especially from 10 a.m. – 2 p.m.
- wear long-sleeve shirts, pants, hats, and sunglasses
-
Inactive ingredients
boron nitride, octyldodecyl stearoyl stearate, glycerin, caprylic/capric triglyceride, magnesium silicate, silica, nylon-12, rosa canina fruit oil, jojoba esters, algae extract, alaria esculenta extract, humic acids, lecithin, betaine, mannitol, stearic acid, diatomaceous earth, zinc sulfate, chlorphenesin. may contain: mica, titanium dioxide, iron oxides, bismuth oxychloride.
- Other information
- Questions or comments?
- SPL UNCLASSIFIED SECTION
- PRINCIPAL DISPLAY PANEL - 14 g Carton - R110
- PRINCIPAL DISPLAY PANEL - 14 g Carton - R170
- PRINCIPAL DISPLAY PANEL - 14 g Carton - R130
- PRINCIPAL DISPLAY PANEL - 14 g Carton - R230
- PRINCIPAL DISPLAY PANEL - 14 g Carton - R150
- PRINCIPAL DISPLAY PANEL - 14 g Carton - R210
- PRINCIPAL DISPLAY PANEL - 14 g Carton - R250
- PRINCIPAL DISPLAY PANEL - 14 g Carton - R270
- PRINCIPAL DISPLAY PANEL - 14 g Carton - R310
- PRINCIPAL DISPLAY PANEL - 14 g Carton - R350
- PRINCIPAL DISPLAY PANEL - 14 g Carton - R330
- PRINCIPAL DISPLAY PANEL - 14 g Carton - R410
- PRINCIPAL DISPLAY PANEL - 14 g Carton - R370
- PRINCIPAL DISPLAY PANEL - 14 g Carton - R450
- PRINCIPAL DISPLAY PANEL - 14 g Carton - R430
- PRINCIPAL DISPLAY PANEL - 14 g Carton - R470
- PRINCIPAL DISPLAY PANEL - 14 g Carton - R550
- PRINCIPAL DISPLAY PANEL - 14 g Carton - R570
- PRINCIPAL DISPLAY PANEL - 14 g Carton - R510
- PRINCIPAL DISPLAY PANEL - 14 g Carton - R530
-
INGREDIENTS AND APPEARANCE
READY FOUNDATION FAIR
titanium dioxide and zinc oxide powderProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:98132-163 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP) Titanium Dioxide 11 g in 100 g Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide 18 g in 100 g Inactive Ingredients Ingredient Name Strength boron nitride (UNII: 2U4T60A6YD) octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C) glycerin (UNII: PDC6A3C0OX) medium-chain triglycerides (UNII: C9H2L21V7U) magnesium silicate (UNII: 9B9691B2N9) silicon dioxide (UNII: ETJ7Z6XBU4) nylon-12 (UNII: 446U8J075B) rosa canina fruit oil (UNII: CR7307M3QZ) alaria esculenta (UNII: EJ9JK8J58D) betaine (UNII: 3SCV180C9W) mannitol (UNII: 3OWL53L36A) stearic acid (UNII: 4ELV7Z65AP) diatomaceous earth (UNII: 2RF6EJ0M85) zinc sulfate (UNII: 89DS0H96TB) chlorphenesin (UNII: I670DAL4SZ) mica (UNII: V8A1AW0880) ferric oxide red (UNII: 1K09F3G675) bismuth oxychloride (UNII: 4ZR792I587) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:98132-163-08 14 g in 1 TRAY; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH FINAL part352 06/01/2012 READY FOUNDATION FAIRLY LIGHT
titanium dioxide and zinc oxide powderProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:98132-164 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP) Titanium Dioxide 11 g in 100 g Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide 18 g in 100 g Inactive Ingredients Ingredient Name Strength boron nitride (UNII: 2U4T60A6YD) octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C) glycerin (UNII: PDC6A3C0OX) medium-chain triglycerides (UNII: C9H2L21V7U) magnesium silicate (UNII: 9B9691B2N9) silicon dioxide (UNII: ETJ7Z6XBU4) nylon-12 (UNII: 446U8J075B) rosa canina fruit oil (UNII: CR7307M3QZ) alaria esculenta (UNII: EJ9JK8J58D) betaine (UNII: 3SCV180C9W) mannitol (UNII: 3OWL53L36A) stearic acid (UNII: 4ELV7Z65AP) diatomaceous earth (UNII: 2RF6EJ0M85) zinc sulfate (UNII: 89DS0H96TB) chlorphenesin (UNII: I670DAL4SZ) mica (UNII: V8A1AW0880) ferric oxide red (UNII: 1K09F3G675) bismuth oxychloride (UNII: 4ZR792I587) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:98132-164-08 14 g in 1 TRAY; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH FINAL part352 06/01/2012 READY FOUNDATION GOLDEN FAIR
titanium dioxide and zinc oxide powderProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:98132-165 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP) Titanium Dioxide 11 g in 100 g Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide 18 g in 100 g Inactive Ingredients Ingredient Name Strength boron nitride (UNII: 2U4T60A6YD) octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C) glycerin (UNII: PDC6A3C0OX) medium-chain triglycerides (UNII: C9H2L21V7U) magnesium silicate (UNII: 9B9691B2N9) silicon dioxide (UNII: ETJ7Z6XBU4) nylon-12 (UNII: 446U8J075B) rosa canina fruit oil (UNII: CR7307M3QZ) alaria esculenta (UNII: EJ9JK8J58D) betaine (UNII: 3SCV180C9W) mannitol (UNII: 3OWL53L36A) stearic acid (UNII: 4ELV7Z65AP) diatomaceous earth (UNII: 2RF6EJ0M85) zinc sulfate (UNII: 89DS0H96TB) chlorphenesin (UNII: I670DAL4SZ) mica (UNII: V8A1AW0880) ferric oxide red (UNII: 1K09F3G675) bismuth oxychloride (UNII: 4ZR792I587) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:98132-165-08 14 g in 1 TRAY; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH FINAL part352 06/01/2012 READY FOUNDATION LIGHT
titanium dioxide and zinc oxide powderProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:98132-166 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP) Titanium Dioxide 11 g in 100 g Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide 18 g in 100 g Inactive Ingredients Ingredient Name Strength boron nitride (UNII: 2U4T60A6YD) octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C) glycerin (UNII: PDC6A3C0OX) medium-chain triglycerides (UNII: C9H2L21V7U) magnesium silicate (UNII: 9B9691B2N9) silicon dioxide (UNII: ETJ7Z6XBU4) nylon-12 (UNII: 446U8J075B) rosa canina fruit oil (UNII: CR7307M3QZ) alaria esculenta (UNII: EJ9JK8J58D) betaine (UNII: 3SCV180C9W) mannitol (UNII: 3OWL53L36A) stearic acid (UNII: 4ELV7Z65AP) diatomaceous earth (UNII: 2RF6EJ0M85) zinc sulfate (UNII: 89DS0H96TB) chlorphenesin (UNII: I670DAL4SZ) mica (UNII: V8A1AW0880) ferric oxide red (UNII: 1K09F3G675) bismuth oxychloride (UNII: 4ZR792I587) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:98132-166-08 14 g in 1 TRAY; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH FINAL part352 06/01/2012 READY FOUNDATION FAIRLY MEDIUM
titanium dioxide and zinc oxide powderProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:98132-167 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP) Titanium Dioxide 11 g in 100 g Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide 18 g in 100 g Inactive Ingredients Ingredient Name Strength boron nitride (UNII: 2U4T60A6YD) octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C) glycerin (UNII: PDC6A3C0OX) medium-chain triglycerides (UNII: C9H2L21V7U) magnesium silicate (UNII: 9B9691B2N9) silicon dioxide (UNII: ETJ7Z6XBU4) nylon-12 (UNII: 446U8J075B) rosa canina fruit oil (UNII: CR7307M3QZ) alaria esculenta (UNII: EJ9JK8J58D) betaine (UNII: 3SCV180C9W) mannitol (UNII: 3OWL53L36A) stearic acid (UNII: 4ELV7Z65AP) diatomaceous earth (UNII: 2RF6EJ0M85) zinc sulfate (UNII: 89DS0H96TB) chlorphenesin (UNII: I670DAL4SZ) mica (UNII: V8A1AW0880) ferric oxide red (UNII: 1K09F3G675) bismuth oxychloride (UNII: 4ZR792I587) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:98132-167-08 14 g in 1 TRAY; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH FINAL part352 06/01/2012 READY FOUNDATION MEDIUM
titanium dioxide and zinc oxide powderProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:98132-168 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP) Titanium Dioxide 11 g in 100 g Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide 18 g in 100 g Inactive Ingredients Ingredient Name Strength boron nitride (UNII: 2U4T60A6YD) octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C) glycerin (UNII: PDC6A3C0OX) medium-chain triglycerides (UNII: C9H2L21V7U) magnesium silicate (UNII: 9B9691B2N9) silicon dioxide (UNII: ETJ7Z6XBU4) nylon-12 (UNII: 446U8J075B) rosa canina fruit oil (UNII: CR7307M3QZ) alaria esculenta (UNII: EJ9JK8J58D) betaine (UNII: 3SCV180C9W) mannitol (UNII: 3OWL53L36A) stearic acid (UNII: 4ELV7Z65AP) diatomaceous earth (UNII: 2RF6EJ0M85) zinc sulfate (UNII: 89DS0H96TB) chlorphenesin (UNII: I670DAL4SZ) mica (UNII: V8A1AW0880) ferric oxide red (UNII: 1K09F3G675) bismuth oxychloride (UNII: 4ZR792I587) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:98132-168-08 14 g in 1 TRAY; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH FINAL part352 06/01/2012 READY FOUNDATION MEDIUM BEIGE
titanium dioxide and zinc oxide powderProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:98132-169 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP) Titanium Dioxide 11 g in 100 g Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide 18 g in 100 g Inactive Ingredients Ingredient Name Strength boron nitride (UNII: 2U4T60A6YD) octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C) glycerin (UNII: PDC6A3C0OX) medium-chain triglycerides (UNII: C9H2L21V7U) magnesium silicate (UNII: 9B9691B2N9) silicon dioxide (UNII: ETJ7Z6XBU4) nylon-12 (UNII: 446U8J075B) rosa canina fruit oil (UNII: CR7307M3QZ) alaria esculenta (UNII: EJ9JK8J58D) betaine (UNII: 3SCV180C9W) mannitol (UNII: 3OWL53L36A) stearic acid (UNII: 4ELV7Z65AP) diatomaceous earth (UNII: 2RF6EJ0M85) zinc sulfate (UNII: 89DS0H96TB) chlorphenesin (UNII: I670DAL4SZ) mica (UNII: V8A1AW0880) ferric oxide red (UNII: 1K09F3G675) bismuth oxychloride (UNII: 4ZR792I587) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:98132-169-08 14 g in 1 TRAY; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH FINAL part352 06/01/2012 READY FOUNDATION GOLDEN MEDIUM
titanium dioxide and zinc oxide powderProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:98132-170 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP) Titanium Dioxide 11 g in 100 g Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide 18 g in 100 g Inactive Ingredients Ingredient Name Strength boron nitride (UNII: 2U4T60A6YD) octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C) glycerin (UNII: PDC6A3C0OX) medium-chain triglycerides (UNII: C9H2L21V7U) magnesium silicate (UNII: 9B9691B2N9) silicon dioxide (UNII: ETJ7Z6XBU4) nylon-12 (UNII: 446U8J075B) rosa canina fruit oil (UNII: CR7307M3QZ) alaria esculenta (UNII: EJ9JK8J58D) betaine (UNII: 3SCV180C9W) mannitol (UNII: 3OWL53L36A) stearic acid (UNII: 4ELV7Z65AP) diatomaceous earth (UNII: 2RF6EJ0M85) zinc sulfate (UNII: 89DS0H96TB) chlorphenesin (UNII: I670DAL4SZ) mica (UNII: V8A1AW0880) ferric oxide red (UNII: 1K09F3G675) bismuth oxychloride (UNII: 4ZR792I587) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:98132-170-08 14 g in 1 TRAY; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH FINAL part352 06/01/2012 READY FOUNDATION MEDIUM TAN
titanium dioxide and zinc oxide powderProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:98132-171 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP) Titanium Dioxide 11 g in 100 g Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide 18 g in 100 g Inactive Ingredients Ingredient Name Strength boron nitride (UNII: 2U4T60A6YD) octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C) glycerin (UNII: PDC6A3C0OX) medium-chain triglycerides (UNII: C9H2L21V7U) magnesium silicate (UNII: 9B9691B2N9) silicon dioxide (UNII: ETJ7Z6XBU4) nylon-12 (UNII: 446U8J075B) rosa canina fruit oil (UNII: CR7307M3QZ) alaria esculenta (UNII: EJ9JK8J58D) betaine (UNII: 3SCV180C9W) mannitol (UNII: 3OWL53L36A) stearic acid (UNII: 4ELV7Z65AP) diatomaceous earth (UNII: 2RF6EJ0M85) zinc sulfate (UNII: 89DS0H96TB) chlorphenesin (UNII: I670DAL4SZ) mica (UNII: V8A1AW0880) ferric oxide red (UNII: 1K09F3G675) bismuth oxychloride (UNII: 4ZR792I587) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:98132-171-08 14 g in 1 TRAY; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH FINAL part352 06/01/2012 READY FOUNDATION TAN
titanium dioxide and zinc oxide powderProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:98132-172 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP) Titanium Dioxide 11 g in 100 g Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide 18 g in 100 g Inactive Ingredients Ingredient Name Strength boron nitride (UNII: 2U4T60A6YD) octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C) glycerin (UNII: PDC6A3C0OX) medium-chain triglycerides (UNII: C9H2L21V7U) magnesium silicate (UNII: 9B9691B2N9) silicon dioxide (UNII: ETJ7Z6XBU4) nylon-12 (UNII: 446U8J075B) rosa canina fruit oil (UNII: CR7307M3QZ) alaria esculenta (UNII: EJ9JK8J58D) betaine (UNII: 3SCV180C9W) mannitol (UNII: 3OWL53L36A) stearic acid (UNII: 4ELV7Z65AP) diatomaceous earth (UNII: 2RF6EJ0M85) zinc sulfate (UNII: 89DS0H96TB) chlorphenesin (UNII: I670DAL4SZ) mica (UNII: V8A1AW0880) ferric oxide red (UNII: 1K09F3G675) bismuth oxychloride (UNII: 4ZR792I587) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:98132-172-08 14 g in 1 TRAY; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH FINAL part352 06/01/2012 READY FOUNDATION WARM TAN
titanium dioxide and zinc oxide powderProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:98132-173 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP) Titanium Dioxide 11 g in 100 g Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide 18 g in 100 g Inactive Ingredients Ingredient Name Strength boron nitride (UNII: 2U4T60A6YD) octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C) glycerin (UNII: PDC6A3C0OX) medium-chain triglycerides (UNII: C9H2L21V7U) magnesium silicate (UNII: 9B9691B2N9) silicon dioxide (UNII: ETJ7Z6XBU4) nylon-12 (UNII: 446U8J075B) rosa canina fruit oil (UNII: CR7307M3QZ) alaria esculenta (UNII: EJ9JK8J58D) betaine (UNII: 3SCV180C9W) mannitol (UNII: 3OWL53L36A) stearic acid (UNII: 4ELV7Z65AP) diatomaceous earth (UNII: 2RF6EJ0M85) zinc sulfate (UNII: 89DS0H96TB) chlorphenesin (UNII: I670DAL4SZ) mica (UNII: V8A1AW0880) ferric oxide red (UNII: 1K09F3G675) bismuth oxychloride (UNII: 4ZR792I587) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:98132-173-08 14 g in 1 TRAY; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH FINAL part352 06/01/2012 READY FOUNDATION GOLDEN TAN
titanium dioxide and zinc oxide powderProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:98132-174 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP) Titanium Dioxide 11 g in 100 g Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide 18 g in 100 g Inactive Ingredients Ingredient Name Strength boron nitride (UNII: 2U4T60A6YD) octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C) glycerin (UNII: PDC6A3C0OX) medium-chain triglycerides (UNII: C9H2L21V7U) magnesium silicate (UNII: 9B9691B2N9) silicon dioxide (UNII: ETJ7Z6XBU4) nylon-12 (UNII: 446U8J075B) rosa canina fruit oil (UNII: CR7307M3QZ) alaria esculenta (UNII: EJ9JK8J58D) betaine (UNII: 3SCV180C9W) mannitol (UNII: 3OWL53L36A) stearic acid (UNII: 4ELV7Z65AP) diatomaceous earth (UNII: 2RF6EJ0M85) zinc sulfate (UNII: 89DS0H96TB) chlorphenesin (UNII: I670DAL4SZ) mica (UNII: V8A1AW0880) ferric oxide red (UNII: 1K09F3G675) bismuth oxychloride (UNII: 4ZR792I587) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:98132-174-08 14 g in 1 TRAY; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH FINAL part352 06/01/2012 READY FOUNDATION DARK
titanium dioxide and zinc oxide powderProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:98132-175 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP) Titanium Dioxide 11 g in 100 g Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide 18 g in 100 g Inactive Ingredients Ingredient Name Strength boron nitride (UNII: 2U4T60A6YD) octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C) glycerin (UNII: PDC6A3C0OX) medium-chain triglycerides (UNII: C9H2L21V7U) magnesium silicate (UNII: 9B9691B2N9) silicon dioxide (UNII: ETJ7Z6XBU4) nylon-12 (UNII: 446U8J075B) rosa canina fruit oil (UNII: CR7307M3QZ) alaria esculenta (UNII: EJ9JK8J58D) betaine (UNII: 3SCV180C9W) mannitol (UNII: 3OWL53L36A) stearic acid (UNII: 4ELV7Z65AP) diatomaceous earth (UNII: 2RF6EJ0M85) zinc sulfate (UNII: 89DS0H96TB) chlorphenesin (UNII: I670DAL4SZ) mica (UNII: V8A1AW0880) ferric oxide red (UNII: 1K09F3G675) bismuth oxychloride (UNII: 4ZR792I587) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:98132-175-08 14 g in 1 TRAY; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH FINAL part352 06/01/2012 READY FOUNDATION MEDIUM DARK
titanium dioxide and zinc oxide powderProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:98132-176 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP) Titanium Dioxide 11 g in 100 g Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide 18 g in 100 g Inactive Ingredients Ingredient Name Strength boron nitride (UNII: 2U4T60A6YD) octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C) glycerin (UNII: PDC6A3C0OX) medium-chain triglycerides (UNII: C9H2L21V7U) magnesium silicate (UNII: 9B9691B2N9) silicon dioxide (UNII: ETJ7Z6XBU4) nylon-12 (UNII: 446U8J075B) rosa canina fruit oil (UNII: CR7307M3QZ) alaria esculenta (UNII: EJ9JK8J58D) betaine (UNII: 3SCV180C9W) mannitol (UNII: 3OWL53L36A) stearic acid (UNII: 4ELV7Z65AP) diatomaceous earth (UNII: 2RF6EJ0M85) zinc sulfate (UNII: 89DS0H96TB) chlorphenesin (UNII: I670DAL4SZ) mica (UNII: V8A1AW0880) ferric oxide red (UNII: 1K09F3G675) bismuth oxychloride (UNII: 4ZR792I587) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:98132-176-08 14 g in 1 TRAY; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH FINAL part352 06/01/2012 READY FOUNDATION WARM DARK
titanium dioxide and zinc oxide powderProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:98132-177 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP) Titanium Dioxide 11 g in 100 g Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide 18 g in 100 g Inactive Ingredients Ingredient Name Strength boron nitride (UNII: 2U4T60A6YD) octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C) glycerin (UNII: PDC6A3C0OX) medium-chain triglycerides (UNII: C9H2L21V7U) magnesium silicate (UNII: 9B9691B2N9) silicon dioxide (UNII: ETJ7Z6XBU4) nylon-12 (UNII: 446U8J075B) rosa canina fruit oil (UNII: CR7307M3QZ) alaria esculenta (UNII: EJ9JK8J58D) betaine (UNII: 3SCV180C9W) mannitol (UNII: 3OWL53L36A) stearic acid (UNII: 4ELV7Z65AP) diatomaceous earth (UNII: 2RF6EJ0M85) zinc sulfate (UNII: 89DS0H96TB) chlorphenesin (UNII: I670DAL4SZ) mica (UNII: V8A1AW0880) ferric oxide red (UNII: 1K09F3G675) bismuth oxychloride (UNII: 4ZR792I587) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:98132-177-08 14 g in 1 TRAY; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH FINAL part352 06/01/2012 READY FOUNDATION GOLDEN DARK
titanium dioxide and zinc oxide powderProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:98132-178 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP) Titanium Dioxide 11 g in 100 g Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide 18 g in 100 g Inactive Ingredients Ingredient Name Strength boron nitride (UNII: 2U4T60A6YD) octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C) glycerin (UNII: PDC6A3C0OX) medium-chain triglycerides (UNII: C9H2L21V7U) magnesium silicate (UNII: 9B9691B2N9) silicon dioxide (UNII: ETJ7Z6XBU4) nylon-12 (UNII: 446U8J075B) rosa canina fruit oil (UNII: CR7307M3QZ) alaria esculenta (UNII: EJ9JK8J58D) betaine (UNII: 3SCV180C9W) mannitol (UNII: 3OWL53L36A) stearic acid (UNII: 4ELV7Z65AP) diatomaceous earth (UNII: 2RF6EJ0M85) zinc sulfate (UNII: 89DS0H96TB) chlorphenesin (UNII: I670DAL4SZ) mica (UNII: V8A1AW0880) ferric oxide red (UNII: 1K09F3G675) bismuth oxychloride (UNII: 4ZR792I587) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:98132-178-08 14 g in 1 TRAY; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH FINAL part352 06/01/2012 READY FOUNDATION MEDIUM DEEP
titanium dioxide and zinc oxide powderProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:98132-179 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP) Titanium Dioxide 11 g in 100 g Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide 18 g in 100 g Inactive Ingredients Ingredient Name Strength boron nitride (UNII: 2U4T60A6YD) octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C) glycerin (UNII: PDC6A3C0OX) medium-chain triglycerides (UNII: C9H2L21V7U) magnesium silicate (UNII: 9B9691B2N9) silicon dioxide (UNII: ETJ7Z6XBU4) nylon-12 (UNII: 446U8J075B) rosa canina fruit oil (UNII: CR7307M3QZ) alaria esculenta (UNII: EJ9JK8J58D) betaine (UNII: 3SCV180C9W) mannitol (UNII: 3OWL53L36A) stearic acid (UNII: 4ELV7Z65AP) diatomaceous earth (UNII: 2RF6EJ0M85) zinc sulfate (UNII: 89DS0H96TB) chlorphenesin (UNII: I670DAL4SZ) mica (UNII: V8A1AW0880) ferric oxide red (UNII: 1K09F3G675) bismuth oxychloride (UNII: 4ZR792I587) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:98132-179-08 14 g in 1 TRAY; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH FINAL part352 06/01/2012 READY FOUNDATION DEEPEST DEEP
titanium dioxide and zinc oxide powderProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:98132-180 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP) Titanium Dioxide 11 g in 100 g Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide 18 g in 100 g Inactive Ingredients Ingredient Name Strength boron nitride (UNII: 2U4T60A6YD) octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C) glycerin (UNII: PDC6A3C0OX) medium-chain triglycerides (UNII: C9H2L21V7U) magnesium silicate (UNII: 9B9691B2N9) silicon dioxide (UNII: ETJ7Z6XBU4) nylon-12 (UNII: 446U8J075B) rosa canina fruit oil (UNII: CR7307M3QZ) alaria esculenta (UNII: EJ9JK8J58D) betaine (UNII: 3SCV180C9W) mannitol (UNII: 3OWL53L36A) stearic acid (UNII: 4ELV7Z65AP) diatomaceous earth (UNII: 2RF6EJ0M85) zinc sulfate (UNII: 89DS0H96TB) chlorphenesin (UNII: I670DAL4SZ) mica (UNII: V8A1AW0880) ferric oxide red (UNII: 1K09F3G675) bismuth oxychloride (UNII: 4ZR792I587) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:98132-180-08 14 g in 1 TRAY; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH FINAL part352 06/01/2012 READY FOUNDATION GOLDEN DEEP
titanium dioxide and zinc oxide powderProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:98132-181 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP) Titanium Dioxide 11 g in 100 g Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide 18 g in 100 g Inactive Ingredients Ingredient Name Strength boron nitride (UNII: 2U4T60A6YD) octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C) glycerin (UNII: PDC6A3C0OX) medium-chain triglycerides (UNII: C9H2L21V7U) magnesium silicate (UNII: 9B9691B2N9) silicon dioxide (UNII: ETJ7Z6XBU4) nylon-12 (UNII: 446U8J075B) rosa canina fruit oil (UNII: CR7307M3QZ) alaria esculenta (UNII: EJ9JK8J58D) betaine (UNII: 3SCV180C9W) mannitol (UNII: 3OWL53L36A) stearic acid (UNII: 4ELV7Z65AP) diatomaceous earth (UNII: 2RF6EJ0M85) zinc sulfate (UNII: 89DS0H96TB) chlorphenesin (UNII: I670DAL4SZ) mica (UNII: V8A1AW0880) ferric oxide red (UNII: 1K09F3G675) bismuth oxychloride (UNII: 4ZR792I587) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:98132-181-08 14 g in 1 TRAY; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH FINAL part352 06/01/2012 READY FOUNDATION WARM DEEP
titanium dioxide and zinc oxide powderProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:98132-182 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength Titanium Dioxide (UNII: 15FIX9V2JP) (Titanium Dioxide - UNII:15FIX9V2JP) Titanium Dioxide 11 g in 100 g Zinc Oxide (UNII: SOI2LOH54Z) (Zinc Oxide - UNII:SOI2LOH54Z) Zinc Oxide 18 g in 100 g Inactive Ingredients Ingredient Name Strength boron nitride (UNII: 2U4T60A6YD) octyldodecyl stearoyl stearate (UNII: 3D47Q6D93C) glycerin (UNII: PDC6A3C0OX) medium-chain triglycerides (UNII: C9H2L21V7U) magnesium silicate (UNII: 9B9691B2N9) silicon dioxide (UNII: ETJ7Z6XBU4) nylon-12 (UNII: 446U8J075B) rosa canina fruit oil (UNII: CR7307M3QZ) alaria esculenta (UNII: EJ9JK8J58D) betaine (UNII: 3SCV180C9W) mannitol (UNII: 3OWL53L36A) stearic acid (UNII: 4ELV7Z65AP) diatomaceous earth (UNII: 2RF6EJ0M85) zinc sulfate (UNII: 89DS0H96TB) chlorphenesin (UNII: I670DAL4SZ) mica (UNII: V8A1AW0880) ferric oxide red (UNII: 1K09F3G675) bismuth oxychloride (UNII: 4ZR792I587) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:98132-182-08 14 g in 1 TRAY; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC MONOGRAPH FINAL part352 06/01/2012 Labeler - Bare Escentuals Beauty Inc. (087008363)